Judge Trims Claims In Securities Class Action Against Drug Maker, Others

PHOENIX — A lead plaintiff in a securities class action lawsuit against a commercial-stage specialty pharmaceutical company and certain of its current and former executive officers has failed to show that...

Already a subscriber? Click here to view full article